Drug policy and law
Monitoring national and Community drug strategies and policies and their impact on the drug situation is a key EMCDDA activity. It has 3 main objectives:
- Monitoring and describing policies, their framework and their relevant context
- Contributing to policy analysis
- Contributing to policy evaluation
The specific areas of work are:
- EU drugs action plan (2009-2012)
- EU drug legislation
- National strategies/action plans on drugs
- National drug legislation
- Coordination arrangements in the field of drugs
- Public expenditure on drugs
Each year, the data collected and analysed by the Centre is summarised in an Annual report on the state of the drugs problem in Europe. You will find an overview of recent developments in national and EU drug policies and strategies in Chapter 1 of the Annual report.
The EMCDDA is also playing a key role in the detection and assessment of new synthetic drugs in the European Union under the terms of a Council Decision on the information exchange, risk-assessment and control of new psychoactive substances.